A framework to support new product introduction in national health systems
Pediatric dolutegravir 10mg dispersible, scored tablets (pDTG)
Tools and resources to support national HIV programs, implementing partners, and community advocates in decision-making regarding pDTG implementation.
Building on the 2020 World AIDS Day announcement on the pediatric dolutegravir 10mg dispersible, scored tablets (pDTG), CHAI is pleased to share a set of resources to support national decision-making on and implementation for the optimal product. Please contact HIVToolkit@clintonhealthaccess.org with any questions about the resources listed here.
Click on a tile to view the latest resources
Featured Tool: CHAI ARV Benchmark Price Comparison List
Provides the latest ARV pricing
Featured Resource: CHAI pDTG Implementation Memo
Guidance to adopt and implement pDTG for national programs
pDTG Resources for Healthcare Workers
Including training curriculum and job aides
Community Resources *New!
Optimal and FASTER CAB members, with technical support from CHAI, developed a multi-media package of treatment literacy and advocacy resources for civil society organizations, community representatives, and national networks of PLHIV to expand access to information on pDTG and support demand generation.
-
pDTG Pocketbook for Caregivers - Print Version (English | French)
-
pDTG Pocketbook for Caregivers - Online Viewing Version (English | French)
-
pDTG Jingle (English)
-
pDTG Administration Poster for Caregivers (English | French)
-
pDTG FAQ for Caregivers and Communities - Formatted (English)
-
pDTG FAQ for Caregivers and Communities - Plain Text (English)
*French and Swahili versions of all community resources will be available soon!
Featured Tool: CHAI ARV Benchmark Price Comparison List
This tool provides Ministries of Health and other partners with the latest pricing of ARVs. CHAI’s ARV Benchmark Price Comparison List consolidates the major price lists for key ARVs and helps highlight the differences between the price lists and the purposes that they serve. This resource was recently updated to reflect the latest pDTG approvals and the pricing agreement that resulted in a ceiling price of $4.50/bottle of 90 tablets (Ex-Works). Further details can be found in the link below.
-
ARV Benchmark Price Comparison List (Q2 2021) *New
Featured Resource: Implementation Memo
This memo lays out the critical information national HIV programs need to know when adopting and implementing pDTG, including a summary of the WHO guidelines, recommended dosing, latest market intelligence on supply availability and pricing, administration best practices, national implementation considerations, as well as frequently asked questions:
Pricing, Quantification & Monitoring Resources
Tools, guidance, and resources to support countries with budgeting, conducting quantification and supply planning, and monitoring uptake:
Implementation Resources
Tools and resources to support management and coordination of product phase-in as rollout activities take place at the facility level.
-
Pediatric ART Weight-Based Prescribing Memo for National HIV Programs *New!
-
DTG Prescribing Algorithms for Children: English | French *NEW!
Press & Announcements
Announcements, press releases, and articles related to updates on pDTG.
Additional press surrounding the pricing announcement was covered in Le Monde, CNN, New York Times, Reuters, The Telegraph, and AfricaNews, among others.
